Blog

Sciformix is committed to sharing ideas and insights with the life science industry and support the development and commercialization of safe and effective products. Our employees and partners share their knowledge and thought leadership.

Dr. Suhasini Sharma

Safety and Risk Management for Biosimilars : A Special Case?


Dr. Suhasini Sharma

Use of biological drugs is increasing exponentially as they provide effective therapeutic alternatives in the treatment of chronic inflammatory diseases and cancers. Being complex to develop and difficult to manufacture, biologics are expensive. Generic versions of biologics, known as ‘follow-on biologics’ or...

Read More

“Identifiability” in Safety Data from Social Media: Challenges and Potential Solutions


Supriya Desai

Biopharmaceutical companies operating in the social media space have a responsibility to monitor any potential adverse events (AEs) communicated through these forums in line with the applicable regulatory guidance from both EMA and US FDA (1-4). Data obtained from several surveyed companies...

Read More

The Impact of Social Media on Drug Safety


Supriya Desai

In recent years, the use of social media forums and channels that focus on various health related topics including diseases and associated treatments has seen an upward trend. However, unlike many other areas in the healthcare industry, the internet and social media...

Read More